References Options

[i_allen]

References

1. Coon, K.D., Dunckley, T., Stephan, D.A. (2004). Biomarker identification in neurologic diseases: improving diagnostics and therapeutics. Expert Rev. Mol. Diagn. 4(3): 361-375.

2. Graeber, M.B., Lowe, J., Radotra, B. (2004). A free community approach to classifying disease. PLoS Med. 1(2): e16.

3. Poser, et al. (1983). Annals of Neurology 13: 227-231.

4. McDonald, W.I., Compston, A., Edan, G., Goodkin, D., Hartung, H.P., Lublin, F.D., McFarland, H.F., Paty, D.W., Polman, C.H., Reingold, S.C., Sandberg-Wollheim, M., Sibley, W., Thompson, A., van den Noort, S., Weinshenker, B.Y. and Wolinsky, J.S. (2001). Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50(1): 121-127.

5. Polman, C.H., Reingold, S.C., Edan, G., Filippi, M., Hartung, H.P., Kappos, L., Lublin, F.D., Metz, L.M., McFarland, H.F., O’Connor, P.W., Sandberg-Wollheim, M., Thompson, A.J., Weinshenker, B.G. and Wolinsky, J.S. (2005). Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann. Neurol. In press.

6. Lublin, F.D. and Reingold, S.C. (1996). Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46(4): 907-911.

7. McKeown and Allen (1978). Neuropathology & Applied Neurobiology 4: 471-482.

8. Tourtellotte, W.W., Rosario, I.P., Conrad, A. and Syndulko, K. (1993). Human neuro-specimen banking 1961-1992. J. Neural. Transm. 39: 5-15.

9. Newcombe, J. and Cuzner, M.L. (1993). Organization and research applications of the UK Multiple Sclerosis Society Tissue Bank. J. Neural Transm. 39: 155-163.

10. Kluver & Barrera (1953). Journal of Experimental Neurology 12: 400.

11. Yao et al. (1994). Brain Pathology 4: 97-100.

12. Bitsch, A., Wegener, C., da Costa, C., Bunkowski, S., Reimers, C.D., Prange, H.W., Bruck, W. (1999). Lesion development in Marburg’s type of acute multiple sclerosis: from inflammation to demyelination. Multiple Sclerosis 5: 138-146.

13. Rodriguez, M. (1993). Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clinic Proceedings 68: 627-636.

14. Sanders, V., Conrad, A.J., Tourtelotte, W.W. (1993). On classification of post-mortem multiple sclerosis plaques for neuroscientists. Journal of Neuroimmunology 46: 207-216.

15. Bruck, W., Porada, P., Poser, S., Rieckmann, P., Hanefeld, F., Kretzschmar, H.A., Lassmann, H. (1995). Monocyte/macrophage differentiation in early multiple sclerosis lesions. Annals of Neurology 38: 788-796.

16. Lucchinetti, C.F., Brück, W., Rodriguez, M., Lassmann, H. (1996). Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathology 6: 259-294.

17. Lucchinetti, C., Bruck, W., Parisi, J., Scheithauer, B., Rodriguez, M., Lassmann, H. (2000). Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47: 707-717.

18. Barnett, M.H., Prineas, J.W. (2004). Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 55(4): 458-468.

19. Prineas, J.W. (2005). Heterogeneity and the pathogenesis of demyelination in relapsing and remitting multiple sclerosis. Multiple Sclerosis 11(1): S4.

20. Brück, W., Stadelmann, C. (2005). The spectrum of multiple sclerosis: new lessons from pathology. Current Opinion in Neurology 18: 221-224.

21. Barnett, M.H., Henderson, A.P., Prineas, J.W. (2006). The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion. Multiple Sclerosis 12(2): 121-132.

22. Bo, L., Vedeler, C.A., Nyland, H.I., Trapp, B.D., Mork, S.J. (2003) Subpial demyelination in the cerebral cortex of multiple sclerosis patients. Journal of Neuropathology and Experimental Neurology 62(7): 723-732.

23. Bo, L., Vedeler, C.A., Nyland, H., Trapp, B.D., Mork, S.J. (2003) Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Multiple Sclerosis 9: 323-331.

24. Vercellino, M., Plano, F., Votta, B., Mutani, R., Giordana, M.T., Cavalla, P. (2005) Grey matter pathology in multiple sclerosis. Journal of Neuropathology and Experimental Neurology 64(12): 1101-1107.




Contributors:


Ingrid Allen

Steve Gentleman

Manuel Graeber

Omar Malik

Richard Nicholas

Richard Reynolds

Federico Roncaroli

Abhi Vora